Treatment of neuroblastoma.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002455:Cell Division; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D008214:Lymphocytes; D009447:Neuroblastoma / Q000097:blood / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D003630:Daunorubicin